Bahram Valamehr - Chief R&D Officer at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Stock Symbol
FATE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Bahram Valamehr - trading volume in the past year for Fate Therapeutics Inc

Holdings reported by Bahram Valamehr for Fate Therapeutics Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 450,000 $1.23 M $2.73 Feb 1, 2024 Direct Common Stock
Common Stock 158,069 $691 K $4.37 Jan 9, 2024 Direct

Transactions reported by Bahram Valamehr for Fate Therapeutics Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership